Studies a clot-removal device for ischemic stroke in adults
Observes a clot-removal device used in adults with acute ischemic stroke.
Plain-language title generated from the registry record
Registry title: Continuous Dual Aspiration Technique With Zoom System for Stroke
Key facts
- Where
- Albany, Baltimore, Buffalo, Cincinnati, Falls Church, Greenville, Huntsville, Kingwood, Knoxville, Lafayette, Marietta, Memphis, Minneapolis, New Orleans, New York, Oklahoma City, Salt Lake City, San Antonio, Spokane, Syracuse, Tampa, The Bronx, and Walnut Creek, United StatesSee the 25 sites
Where in United States
- Albany Medical CollegeAlbany, United StatesTaking people
- University of MarylandBaltimore, United StatesTaking people
- University at Buffalo NeurosurgeryBuffalo, United StatesTaking people
- TriHealth Good Samaritan HospitalCincinnati, United StatesTaking people
- Inova Fairfax Medical CampusFalls Church, United StatesTaking people
- Prisma Health-UpstateGreenville, United StatesTaking people
- Huntsville HospitalHuntsville, United StatesTaking people
- HCA Houston Healthcare KingwoodKingwood, United StatesTaking people
- Fort Sanders Regional Medical CenterKnoxville, United StatesTaking people
- Ochsner Clinic Foundation (Lafayette)Lafayette, United StatesTaking people
- Wellstar Kennestone HospitalMarietta, United StatesTaking people
- Semmes Murphey FoundationMemphis, United StatesTaking people
- Allina HealthMinneapolis, United StatesTaking people
- Ochsner Clinic FoundationNew Orleans, United StatesTaking people
- Icahn School of Medicine at Mount SinaiNew York, United StatesTaking people
- Weill Cornell MedicineNew York, United StatesTaking people
- University of Oklahoma Health Science CenterOklahoma City, United StatesTaking people
- University of UtahSalt Lake City, United StatesTaking people
- Methodist Healthcare System of San AntonioSan Antonio, United StatesTaking people
- University of Texas Science Health Center at San AntonioSan Antonio, United StatesTaking people
- Providence Sacred Heart Medical Center and Children's HospitalSpokane, United StatesTaking people
- SUNY Upstate Medical CenterSyracuse, United StatesTaking people
- University of South FloridaTampa, United StatesTaking people
- Montefiore Medical CenterThe Bronx, United StatesTaking people
- John Muir HealthWalnut Creek, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Imperative Care, Inc.
- Trial code
- NCT07491952
- Record updated
- 6 November 2026
- Original description
This study is designed to evaluate the effectiveness, safety and clinical performance of ADAPT 2.0, first-line aspiration neurothrombectomy with Zoom System with Continuous Dual Aspiration Technique (CDAT).Read full original descriptionShow less
Clinical Evaluation of Continuous Dual Aspiration Technique With Zoom System for Stroke (ADAPT 2.0)
This study is designed to evaluate the effectiveness, safety and clinical performance of ADAPT 2.0, first-line aspiration neurothrombectomy with Zoom System with Continuous Dual Aspiration Technique (CDAT).
Inclusion: Subject is ≥ 18 years of age; Subject or legally authorized representative has provided written informed consent prior to any study-specific procedures and no later than 72 hours after the index procedure; Pre-stroke mRS 0-2; Subject is undergoing or has undergone an aspiration thrombectomy using the Zoom System with Continuous Dual Aspiration Technique (CDAT) as the first line device within its intended use.
Exclusion: Subject is currently enrolled in or planned to be enrolled in any concurrent interventional study that may impact the safety or performance data collected in this study; Any intracranial hemorrhage in the qualifying head CT or MRI; Subjects with a life expectancy of less than 6 months; Female subject who is known to be pregnant at time of admission; Presence of tandem internal carotid artery occlusion, multiple occlusion locations (e.g., cavernous ICA and M1, separate M2 occlusions, etc.), or occlusions in multiple territories (e.g., MCA and ACA, bilateral, etc.); In the opinion of the Investigator, the patient is not a suitable candidate for intervention with the Zoom System.